Purchase Order 75F40121P00439
Award Date
8/10/21
Potential Completion Date
9/24/24
Potential Value
$35K
Federal Agency
Food and Drug Administration
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bedford Park, IL 60501, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $70,930.76, is for preventive maintenance and repair services for Illumina's MiSeq genetic sequencing instruments. The contract has an ultimate completion date of August 31, 2025 and does not utilize any set-aside designations. Illumina is a specialized technology provider...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $39,591.55, is for the provision of whole genome reagent kits. The contract does not have a set-aside designation. Illumina is an experienced federal contractor, having been awarded multiple prime contracts and grants across various agencies, including the National Institutes...
This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The $87,870.00 contract is for the provision of a MiSeq DNA sequencing system and related consumables. The award has no set-aside designation. Illumina has previously been awarded prime contracts and subcontracts by various federal agencies, including the National Institutes of Health (NIH), Centers for Disease...
This $81,810 firm fixed price delivery order was awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the provision of a MiSeq instrument and does not have a set-aside designation. Illumina has previously been awarded prime contracts and subcontracts by various federal agencies, including the National Institutes of Health (NIH), Centers for Disease Control and Prevention...
This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for preventative maintenance services on MiSeq benchtop sequencing instruments. The $184,226.00 contract has an ultimate completion date of December 5, 2016. Illumina is a for-profit manufacturer and provider of genomic sequencing and analysis solutions. Through prior federal contracts, Illumina has supplied a range of sequencing systems, reagents, and related services to...
This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for preventative maintenance and reagents for the company's MiSeq benchtop sequencer. The total ceiling value of the contract is $292,446.20, with a performance period ending on December 5, 2016. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has provided similar products and services to support genomic research and diagnostics for...
This federal contract award is for the provision of a MiSeq Benchtop Sequencer, associated reagent kits, and preventative maintenance services. The contract, valued at $239,377.06, was awarded to Illumina, Inc., a for-profit manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis. The award was made by the Food and Drug Administration (FDA), a civilian federal agency, on a firm fixed-price basis with no set-aside provisions. Illumina has previously...
This firm fixed-price delivery order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The $12,058.24 contract is for the procurement of Illumina sequencing kits and does not have a set-aside designation. Illumina has been awarded multiple prime federal contracts and grants, primarily focused on providing advanced genomic sequencing...
This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract has a ceiling value of $237,188.40 and no set-aside designation. Illumina will provide a range of sequencing systems, including NextSeq, NovaSeq, MiSeq, and iSeq, along with associated reagents, consumables, sample prep kits, sequencing chips, support plans, maintenance services, and...
This firm fixed-price purchase order was awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, to provide a diagnostic check and system upgrades for the MiSeq Whole Genome Sequencer at six FDA laboratories. The $84,733.20 contract has a completion date of December 31, 2022 and was sole-sourced to Illumina due to the proprietary nature of the MiSeq technology. Illumina has previously provided sequencing systems,...